Pharmaceutical | All Other | Total | |||||||||
Year Ended December 31, 2013 | |||||||||||
Included in segment profits: | |||||||||||
Equity income from affiliates | $ | 88 | $ | 475 | $ | 563 | |||||
Depreciation and amortization | (27 | ) | (22 | ) | (49 | ) | |||||
Year Ended December 31, 2012 | |||||||||||
Included in segment profits: | |||||||||||
Equity income from affiliates | $ | 36 | $ | 504 | $ | 540 | |||||
Depreciation and amortization | (25 | ) | (20 | ) | (45 | ) | |||||
Year Ended December 31, 2011 | |||||||||||
Included in segment profits: | |||||||||||
Equity income from affiliates | $ | 59 | $ | 510 | $ | 569 | |||||
Depreciation and amortization | (51 | ) | (20 | ) | (71 | ) |